We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+5.26%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$224B
AUM Growth
+$21B
Cap. Flow
+$7.48B
Cap. Flow %
3.33%
Top 10 Hldgs %
24.57%
Holding
10,190
New
1,427
Increased
4,227
Reduced
3,278
Closed
1,044

Top Buys

Rank Stock Value
1
MS icon
Morgan Stanley
MS
+$798M
2
T icon
AT&T
T
+$527M
3
MCHP icon
Microchip Technology
MCHP
+$472M
4
NFLX icon
Netflix
NFLX
+$446M
5
PNC icon
PNC Financial Services
PNC
+$444M

Top Sells

Rank Stock Value
1
GS icon
Goldman Sachs
GS
+$694M
2
KEY icon
KeyCorp
KEY
+$401M
3
DE icon
Deere & Co
DE
+$322M
4
CSX icon
CSX Corp
CSX
+$318M
5
NXPI icon
NXP Semiconductors
NXPI
+$314M

Sector Composition

Rank Sector Weight
1 Financials 5.93%
2 Technology 4.66%
3 Healthcare 4.45%
4 Industrials 4.14%
5 Consumer Discretionary 3.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NGL icon
7976
CALL
NGL Energy Partners
NGL
$2.24B
$211K ﹤0.01%
18,200
-2,700
-13% -$32.8K
SRG
7977
Seritage Growth Properties
SRG
$128M
$211K ﹤0.01%
4,444
-31,453
-88% -$1.49M
PRNB
7978
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
$211K ﹤0.01%
+7,206
New +$203K
CNNE icon
7979
CALL
Cannae Holdings
CNNE
$635M
$210K ﹤0.01%
10,000
-800
-7% -$15.6K
GYRE icon
7980
PUT
Gyre Therapeutics
GYRE
$708M
$210K ﹤0.01%
2,600
-253
-9% -$20K
INSG icon
7981
PUT
Inseego
INSG
$77M
$210K ﹤0.01%
+5,450
New +$151K
PAYC icon
7982
Paycom
PAYC
$9.83B
$210K ﹤0.01%
1,350
-179,142
-99% -$24.1M
SCHL icon
7983
PUT
Scholastic
SCHL
$781M
$210K ﹤0.01%
+4,500
New +$193K
STN icon
7984
Stantec
STN
$8.41B
$210K ﹤0.01%
+8,435
New +$216K
DIT icon
7985
AMCON Distributing
DIT
$66.4M
$209K ﹤0.01%
3,608
-480
-12% -$27.3K
SBIO icon
7986
PUT
ALPS Medical Breakthroughs ETF
SBIO
$215M
$209K ﹤0.01%
+5,300
New +$201K
SNA icon
7987
Snap-on
SNA
$20.9B
$209K ﹤0.01%
1,139
-1,454
-56% -$253K
WIP icon
7988
State Street SPDR FTSE International Government Inflation-Protected Bond ETF
WIP
$474M
$209K ﹤0.01%
+3,965
New +$211K
WLDN icon
7989
Willdan Group
WLDN
$1.32B
$209K ﹤0.01%
+6,141
New +$192K
FPRX
7990
PUT
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$209K ﹤0.01%
+15,000
New +$223K
ESNT icon
7991
PUT
Essent Group
ESNT
$6.25B
$208K ﹤0.01%
4,700
-5,600
-54% -$230K
GYRE icon
7992
CALL
Gyre Therapeutics
GYRE
$708M
$208K ﹤0.01%
2,573
-4,387
-63% -$348K
LII icon
7993
Lennox International
LII
$14.6B
$208K ﹤0.01%
952
-3,858
-80% -$840K
SMN icon
7994
ProShares UltraShort Materials
SMN
$3.83M
$208K ﹤0.01%
+985
New +$201K
WTS icon
7995
PUT
Watts Water Technologies
WTS
$12.8B
$208K ﹤0.01%
2,500
-4,100
-62% -$339K
SBOW
7996
DELISTED
SilverBow Resources, Inc.
SBOW
$208K ﹤0.01%
+7,790
New +$231K
FLOW
7997
CALL
DELISTED
SPX FLOW, Inc.
FLOW
$208K ﹤0.01%
+4,000
New +$189K
SDRL
7998
CALL
DELISTED
Seadrill Limited Common Stock
SDRL
$208K ﹤0.01%
8,400
+3,251
+63% +$66K
DBRG icon
7999
PUT
DigitalBridge
DBRG
$2.94B
$207K ﹤0.01%
8,500
-7,625
-47% -$187K
MANU icon
8000
CALL
Manchester United
MANU
$4.17B
$207K ﹤0.01%
+9,200
New +$210K

Similar funds

Ken Griffin's Q3 2018 Portfolio in Review

As of Q3 2018, Ken Griffin held 10,190 positions worth $224B, up 10% from $203B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Ken Griffin deployed $7.48B of net new capital in Q3 2018, opening 1,427 new positions and adding to 4,227 existing holdings. Its largest new stake was Alibaba: 1,030,311 shares worth $170M.

By sector, the portfolio is most concentrated in Financials at 5.9% of assets, down from 6.2% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Goldman Sachs, an estimated $694M trimmed.

  • Ken Griffin's largest Q3 2018 buy was Alibaba: 1,030,311 shares worth $170M.
  • Ken Griffin added most to Morgan Stanley in Q3 2018, an estimated $798M increase.
  • Ken Griffin's biggest Q3 2018 reduction was Goldman Sachs, cutting an estimated $694M.
  • Ken Griffin fully exited XL Group Ltd. in Q3 2018, selling an estimated $207M.
  • Ken Griffin's ten largest holdings make up 25% of its $224B portfolio in Q3 2018.
  • Ken Griffin opened 1,427 new positions and closed 1,044 in Q3 2018.
  • Ken Griffin's portfolio value rose 10% quarter-over-quarter to $224B.

Based on Citadel Advisors's 13F filing for Q3 2018, filed 13 Nov 2018.